Zonisamide for the Treatment of Parkinson Disease: A Current Update
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Zonisamide for the Treatment of Parkinson Disease: A Current Update
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 14, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-12-21
DOI
10.3389/fnins.2020.574652
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emerging Role of Sirtuin 2 in Parkinson’s Disease
- (2020) Yumei Liu et al. Frontiers in Aging Neuroscience
- Genome-wide association study identifies zonisamide responsive gene in Parkinson’s disease patients
- (2020) Pei-Chieng Cha et al. JOURNAL OF HUMAN GENETICS
- The effects of zonisamide on L-DOPA–induced dyskinesia in Parkinson's disease model mice
- (2019) Hiromi Sano et al. NEUROCHEMISTRY INTERNATIONAL
- Comparison of zonisamide with non-levodopa, anti-Parkinson's disease drugs in the incidence of Parkinson's disease-relevant symptoms
- (2019) Hirotaka Iwaki et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- The anti-parkinsonian drug zonisamide reduces neuroinflammation: Role of microglial Na v 1.6
- (2018) Muhammad M. Hossain et al. EXPERIMENTAL NEUROLOGY
- Pharmacological characterization of nicotine-induced tremor: Responses to anti-tremor and anti-epileptic agents
- (2018) Naofumi Kunisawa et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Zonisamide cotreatment delays striatal dopamine transporter reduction in Parkinson disease: A retrospective, observational cohort study
- (2018) Ken Ikeda et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
- (2018) Susan H. Fox et al. MOVEMENT DISORDERS
- The factors associated with impulse control behaviors in Parkinson's disease: A 2-year longitudinal retrospective cohort study
- (2018) Tomoya Kon et al. Brain and Behavior
- Different generations of type-B monoamine oxidase inhibitors in Parkinson’s disease: from bench to bedside
- (2018) Marika Alborghetti et al. Current Neuropharmacology
- Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine
- (2018) Margherita Fabbri et al. MOVEMENT DISORDERS
- Zonisamide Enhances Motor Effects of Levodopa, Not of Apomorphine, in a Rat Model of Parkinson’s Disease
- (2018) Haruo Nishijima et al. Parkinsons Disease
- Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson’s Disease
- (2018) Shin-Ichi Ueno et al. Cells
- Zonisamide attenuates lactacystin-induced parkinsonism in mice without affecting system x c −
- (2017) Eduard Bentea et al. EXPERIMENTAL NEUROLOGY
- Combination Therapy with Zonisamide and Antiparkinson Drugs for Parkinson’s Disease: A Meta-Analysis
- (2017) Shinji Matsunaga et al. JOURNAL OF ALZHEIMERS DISEASE
- Zonisamide ameliorates levodopa-induced dyskinesia and reduces expression of striatal genes in Parkinson model rats
- (2017) Mitsuaki Oki et al. NEUROSCIENCE RESEARCH
- Zonisamide inhibits monoamine oxidase and enhances motor performance and social activity
- (2017) Maiko T. Uemura et al. NEUROSCIENCE RESEARCH
- Monitoring of 30 marker candidates in early Parkinson disease as progression markers
- (2016) Brit Mollenhauer et al. NEUROLOGY
- Zonisamide suppresses endoplasmic reticulum stress-induced neuronal cell damage in vitro and in vivo
- (2015) Saori Tsujii et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Modulation of endoplasmic reticulum stress in Parkinson's disease
- (2015) Saori Tsujii et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Zonisamide reduces nigrostriatal dopaminergic neurodegeneration in a mouse genetic model of Parkinson's disease
- (2015) Hiromi Sano et al. JOURNAL OF NEUROCHEMISTRY
- Zonisamide improves wearing-off in Parkinson's disease: A randomized, double-blind study
- (2015) Miho Murata et al. MOVEMENT DISORDERS
- Zonisamide Enhances Neurite Elongation of Primary Motor Neurons and Facilitates Peripheral Nerve Regeneration In Vitro and in a Mouse Model
- (2015) Hideki Yagi et al. PLoS One
- The T-type calcium channel as a new therapeutic target for Parkinson’s disease
- (2014) Ya-Chin Yang et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Zonisamide Attenuates α-Synuclein Neurotoxicity by an Aggregation-Independent Mechanism in a Rat Model of Familial Parkinson’s Disease
- (2014) Shigeki Arawaka et al. PLoS One
- Initial Treatment of Parkinson’s Disease: An Update
- (2013) Scott Kaplan et al. Current Treatment Options in Neurology
- Non-dopaminergic Treatments for Motor Control in Parkinson’s Disease
- (2013) Susan H. Fox DRUGS
- Zonisamide: A review of the clinical and experimental evidence for its use in Parkinson′s disease
- (2013) NeetaD Grover et al. INDIAN JOURNAL OF PHARMACOLOGY
- Signals through the Striatopallidal Indirect Pathway Stop Movements by Phasic Excitation in the Substantia Nigra
- (2013) H. Sano et al. JOURNAL OF NEUROSCIENCE
- Protective Effects of Zonisamide Against Rotenone-Induced Neurotoxicity
- (2013) Salvatore Condello et al. NEUROCHEMICAL RESEARCH
- Zonisamide regulates basal ganglia transmission via astroglial kynurenine pathway
- (2013) Kouji Fukuyama et al. NEUROPHARMACOLOGY
- Endoplasmic Reticulum Stress and Parkinson’s Disease: The Role of HRD1 in Averting Apoptosis in Neurodegenerative Disease
- (2013) Tomohiro Omura et al. Oxidative Medicine and Cellular Longevity
- Zonisamide for seizures in Parkinson's disease with dementia
- (2013) Mario Tombini et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Systemic administration of valproic acid and zonisamide promotes differentiation of induced pluripotent stem cell–derived dopaminergic neurons
- (2013) Tatsuya Yoshikawa et al. Frontiers in Cellular Neuroscience
- Effect of zonisamide co-administration with levodopa on global gene expression in the striata of rats with Parkinson’s disease
- (2012) Yuto Ueda et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Zonisamide Attenuates MPP(+)-Induced Oxidative Toxicity Through Modulation of Ca2+ Signaling and Caspase-3 Activity in Neuronal PC12 Cells
- (2012) Vedat Ali Yürekli et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- New Agents Promote Neuroprotection in Parkinson’s Disease Models
- (2012) Claudia Maria Miranda Santos CNS & Neurological Disorders-Drug Targets
- Zonisamide up-regulated the mRNAs encoding astrocytic anti-oxidative and neurotrophic factors
- (2012) ME Choudhury et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Actions of Xanthurenic Acid, a putative endogenous Group II metabotropic glutamate receptor agonist, on sensory transmission in the thalamus
- (2012) C.S. Copeland et al. NEUROPHARMACOLOGY
- Actigraphic study of tremor before and after treatment with zonisamide in patients with Parkinson's disease
- (2012) Soichiro Mochio et al. PARKINSONISM & RELATED DISORDERS
- Impulse control disorders in parkinson disease: A multicenter case-control study
- (2011) Valerie Voon et al. ANNALS OF NEUROLOGY
- Zonisamide-induced long-lasting recovery of dopaminergic neurons from MPTP-toxicity
- (2011) Mohammed Emamussalehin Choudhury et al. BRAIN RESEARCH
- Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease
- (2011) Yong-Hee Rhee et al. JOURNAL OF CLINICAL INVESTIGATION
- HRD1 Levels Increased by Zonisamide Prevented Cell Death and Caspase-3 Activation Caused by Endoplasmic Reticulum Stress in SH-SY5Y Cells
- (2011) Tomohiro Omura et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Efficacy of zonisamide in a case of Parkinson’s disease with intractable resting and re-emergent tremor
- (2010) M. Iijima et al. EUROPEAN JOURNAL OF NEUROLOGY
- Zonisamide: Aspects in neuroprotection
- (2010) Thomas W. Rösler et al. EXPERIMENTAL NEUROLOGY
- Zonisamide in managing impulse control disorders in Parkinson’s disease
- (2010) Pedro Emilio Bermejo et al. JOURNAL OF NEUROLOGY
- Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)neurotoxicity in mice
- (2010) Hironori Yokoyama et al. METABOLIC BRAIN DISEASE
- REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century
- (2010) D. O. Claassen et al. NEUROLOGY
- Zonisamide reduces cell death in SH-SY5Y cells via an anti-apoptotic effect and by upregulating MnSOD
- (2010) Sumihiro Kawajiri et al. NEUROSCIENCE LETTERS
- Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats
- (2010) G. Hargus et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neuroprotective effects of zonisamide target astrocyte
- (2009) Masato Asanuma et al. ANNALS OF NEUROLOGY
- Zonisamide
- (2009) Lily P.H. Yang et al. CNS DRUGS
- Electrophysiological actions of zonisamide on striatal neurons: Selective neuroprotection against complex I mitochondrial dysfunction
- (2009) Cinzia Costa et al. EXPERIMENTAL NEUROLOGY
- The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: Clinical relevance
- (2009) Patricia K. Sonsalla et al. EXPERIMENTAL NEUROLOGY
- A Novel Anti-Parkinsonian Agent, Zonisamide, Attenuates MPTP-Induced Neurotoxicity in Mice
- (2009) Ryohei Yano et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Zonisamide enhances delta receptor-associated neurotransmitter release in striato-pallidal pathway
- (2009) S. Yamamura et al. NEUROPHARMACOLOGY
- Review: A review of the use of zonisamide in Parkinson’s disease
- (2009) Pedro Emilio Bermejo et al. Therapeutic Advances in Neurological Disorders
- Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation
- (2007) Masato Asanuma et al. NEUROSCIENCE RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation